How have US colorectal cancer mortality trends changed in the past 20 years?

Jia Yi Tan,Yong‐Hao Yeo,Wern Lynn Ng,Zhi Ven Fong,Justin T. Brady
DOI: https://doi.org/10.1002/ijc.34926
2024-03-27
International Journal of Cancer
Abstract:What's new Using CDC Wonder data from 1999 to 2020, this study examines mortality trends in colorectal cancer in the United States, delving into subtypes including colon, rectosigmoid, and rectal cancer. Despite an overall decrease in colorectal cancer mortality, the results reveal increasing mortality trends for young‐onset colorectal cancer and rectosigmoid cancer over the past two decades. Disparities also persist in terms of sex, race, geographic region, and urbanization level. The findings underscore the need for more targeted public health measures and focused care to address these disparities. In the last two decades, colorectal cancer (CRC) mortality has been decreasing in the United States. However, the mortality trends for the different subtypes of CRC, including different sides of colon, rectosigmoid, and rectal cancer remain unclear. We analyzed the mortality trends of different subtypes of CRC based on Centers for Disease Control and Prevention's Wide‐Ranging Online Data for Epidemiologic Research data from 1999 to 2020. We calculated age‐adjusted mortality rates (AAMR) per 100,000 individuals and examined the trends over time by estimating the average annual percent change (AAPC) using the Joinpoint Regression Program. Our study shows that the overall CRC rates decreased significantly from 26.42 to 15.98 per 100,000 individuals, with an AAPC of −2.41. However, the AAMR of rectosigmoid cancer increased significantly from 0.82 to 1.08 per 100,000 individuals, with the AAPC of +1.10. Men and Black individuals had the highest AAMRs respectively (23.90 vs. 26.93 per 100,000 individuals). The overall AAMR of CRC decreased for those aged ≥50 years but increased significantly from 1.02 to 1.58 per 100,000 individuals for those aged 15–49 years, with an AAPC of +0.75. Rural populations had a higher AAMR than the urban populations (22.40 vs. 19.60 per 100,000 individuals). Although overall CRC mortality declined, rising trends in young‐onset CRC and rectosigmoid cancer warrant attention. Disparities persist in terms of sex, race, and geographic region, and urbanization level, emphasizing the need for targeted public health measures.
oncology
What problem does this paper attempt to address?